Corrigendum: ACTIVATE-2: A double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk.
Frontiers in immunology
View this publicationFrontiers in immunology
View this publicationFrontiers in cardiovascular medicine
View this publicationeLife
View this publicationEpilepsia open
View this publicationMed (New York, N.Y.)
View this publicationScientific reports
View this publicationJournal of fungi (Basel, Switzerland)
View this publicationCell stress & chaperones
View this publicationThe Lancet. Infectious diseases
View this publicationFrontiers in immunology
View this publication